Effects of 5 alpha-reductase inhibition by finasteride on lipoproteins and body composition in males affected by benign prostatic hyperplasia (BPH).
Denti
L
L
Chair of Geriatrics, University of Parma, Italy.
Pasolini
G
G
Cortellini
P
P
Sanfelici
L
L
Benedetti
R
R
Cecchetti
A
A
Ferretti
S
S
Banchini
A
A
Ablondi
F
F
Valenti
G
G
D000368:Aged; D001823:Body Composition / Q000187:drug effects*; D042944:Cholestenone 5 alpha-Reductase; D013196:Dihydrotestosterone / Q000097:blood; D004791:Enzyme Inhibitors / Q000627:therapeutic use*; D018120:Finasteride / Q000627:therapeutic use*; D006801:Humans; D008074:Lipoproteins / Q000097:blood*; D008297:Male; D008875:Middle Aged; D010088:Oxidoreductases / Q000037:antagonists & inhibitors*; D011470:Prostatic Hyperplasia / Q000097:blood / Q000188:drug therapy* / Q000201:enzymology* / Q000473:pathology*
D004791:Enzyme Inhibitors; D008074:Lipoproteins; D013196:Dihydrotestosterone; D018120:Finasteride; D010088:Oxidoreductases; D042944:Cholestenone 5 alpha-Reductase